Tissue-specific effect of VDR gene polymorphisms on the response to calcitriol

Journal of Nephrology

Volumn 21, Issue 6, 2008, Pages 843-849

  Alvarez Hernandez, Daniel ^a   Naves Diaz, Manuel ^a   Gomez Alonso, Carlos ^a   Coto, Eliecer ^a   Cannata Andia, Jorge B ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

Author keywords

Calcitriol; Osteoblasts; Parathyroid glands; Polymorphisms; Vitamin D receptor

Indexed keywords

CALCITRIOL; OSTEOCALCIN; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; VITAMIN;

BONE DENSITY; BONE MASS; DNA POLYMORPHISM; FRAGILITY FRACTURE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE LOCATION; GENE TARGETING; GENOTYPE; HAPLOTYPE; HORMONE ACTION; HORMONE METABOLISM; HORMONE SYNTHESIS; HUMAN; OSTEOBLAST; PARATHYROID GLAND; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; BONE; DRUG EFFECT; GENETIC POLYMORPHISM; GENETICS; METABOLISM; OSTEOPOROSIS;

BONE AND BONES; BONE DENSITY; CALCITRIOL; HUMANS; OSTEOPOROSIS; PARATHYROID GLANDS; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; VITAMINS;

EID: 62749205888     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Alvarez-Hernandez D, Gomez-Alonso C, Cannata-Andía JB. Vitamin D supplementation: what is right? Clinical Cases in Mineral and Bone Metabolism. 2006;3:71-75.
2. Dusso AS, Brown A, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol. 2005;289:F8-F28.
3. Cozzolino M, Gallieni M, Brancaccio D, Arcidiacono T, Bianchi G, Vezzoli G. Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure. J Nephrol. 2006;19:566-577.
4. Brancaccio D, Cozzolino M, Galassi A, et al. Management of secondary hyperparathyroidism in uremic patients: the role of the new vitamin D analogs. J Nephrol. 2007;20:3-9.
5. Miyamoto T, Kakizawa T, Ichikawa K, et al. The role of hinge domain in heterodimerization and specific DNA recognition by nuclear receptors. Mol Cell Endocrinol. 2001;181:229-238.
6. Taymans SE, Pack S, Pak E, et al. The human vitamin D receptor gene (VDR) is localized to region 12cen-q12 by fluorescent in situ hybridization and radiation hybrid mapping: genetic and physical VDR map. J Bone Miner Res. 1999;14:1163-1166.
7. Brown AJ, Zhong M, Finch J, Ritter C, Slatopolsky E. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands. Endocrinology. 1995;136:1419-1425.
8. Kato S, Yoshizazawa T, Kitanaka S, Murayama A, Takeyama K. Molecular genetics of vitamin D-dependent hereditary rickets. Horm Res. 2002;57:73-78.
9. Malloy PJ, Wang J, Peng L, et al. A unique insertion/duplication in the VDR gene that truncates the VDR causing hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia. Arch Biochem Biophys. 2007;460:285-292.
10. Ensembl Gene Variation Report for ENSG00000111424. Ensemble Human Gene SN. Available at: http://www.ensembl.org/Homo_sapiens/ genesnpview?db=core;gene=ENSG00000111424. Accessed October 15, 2008.
11. Alvarez-Hernandez D, Naves M, Diaz-Lopez JB, Gomez C, Santamaria I, Cannata-Andia JB. Influence of polymorphisms in VDR and COLIA1 genes on the risk of osteoporotic fractures in aged men. Kidney Int Suppl. 2003;63:14-18
12. Gomez C, Naves ML, Barrios Y, et al. Vitamin D receptor gene polymorphisms, bone mass, bone loss and prevalence of vertebral fracture: differences in postmenopausal women and men. Osteoporos Int. 1999;10:175-182.
13. Morrison NA, Qi JC, Tokita A, et al. Prediction of bone density from vitamin D receptor alleles. Nature. 1994;367:284-287.
14. Naves M, Alvarez-Hernandez D, Fernandez-Martin JL, et al. Effect of VDR gene polymorphisms on osteocalcin secretion in calcitriol-stimulated human osteoblasts. Kidney Int Suppl. 2003;63:S23-S27.
15. Thakkinstian A, D'Este C, Eisman J, Nguyen T, Attia J. Meta-analysis of molecular association studies: vitamin D receptor gene polymorphisms and BMD as a case study. J Bone Miner Res. 2004;19:419-428.
16. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338:143-156.
17. Alvarez-Hernandez D, Naves M, Santamaria I, Menarguez J, Torregrosa V, Cannata J. Response of parathyroid glands to calcitriol in culture: is this response mediated by the genetic polymorphisms in vitamin D receptor? Kidney Int Suppl. 2003;63:S19-S22.
18. Carling T, Rastad J, Akerstrom G, Westin G. Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors. J Clin Endocrinol Metab. 1998;83:2255-2259.
19. Jofre R, Menarguez J, Polo JR, et al. The vitamin D receptor gene polymorphism and parathyroid function. Nephrol Dial Transplant. 1999;14:1336-1337.
20. Marco MP, Martinez I, Amoedo ML, et al. Vitamin D receptor genotype influences parathyroid hormone and calcitriol levels in predialysis patients. Kidney Int. 1999;56:1349-1353.
21. Yokoyama K, Shigematsu T, Tsukada T, et al. Apa I polymorphism in the vitamin D receptor gene may affect the parathyroid response in Japanese with end-stage renal disease. Kidney Int. 1998;53:454-458.
22. Motohashi Y, Yamada S, Yanagawa T, et al. Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population. J Clin Endocrinol Metab. 2003;88:3137-3140.
23. Purdue MP, Lan Q, Kricker A, Vajdic CM, Rothman N, Armstrong BK. Vitamin D receptor gene polymorphisms and risk of non-Hodgkin's lymphoma. Haematologica. 2007;92:1145-1146.
24. Saeki H, Asano N, Tsunemi Y, et al. Polymorphisms of vitamin D receptor gene in Japanese patients with psoriasis vulgaris. J Dermatol Sci. 2002;30:167-171.
25. Slattery ML, Neuhausen SL, Hoffman M, et al. Dietary calcium, vitamin D, VDR genotypes and colorectal cancer. Int J Cancer. 2004;111:750-756.
26. Wilkinson RJ, Llewelyn M, Toossi Z, et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet. 2000;355:618-621.
27. Eccleshall TR, Garnero P, Gross C, Delmas PD, Feldman D. Lack of correlation between start codon polymorphism of the vitamin D receptor gene and bone mineral density in premenopausal French women: the OFELY study. J Bone Miner Res. 1998;13:31-35.
28. Garnero P, Borel O, Sornay-Rendu E, Delmas PD. Vitamin D receptor gene polymorphisms do not predict bone turnover and bone mass in healthy premenopausal women. J Bone Miner Res. 1995;10:1283-1288.
29. Houston LA, Grant SF, Reid DM, Ralston SH. Vitamin D receptor polymorphism, bone mineral density, and osteoporotic vertebral fracture: studies in a UK population. Bone. 1996;18:249-252.
30. Uitterlinden AG, Pols HA, Burger H, et al. A large-scale population-based study of the association of vitamin D receptor gene polymorphisms with bone mineral density. J Bone Miner Res. 1996;11:1241-1248.
31. Fang Y, Rivadeneira F, van Meurs JB, Pols HA, Ioannidis JP, Uitterlinden AG. Vitamin D receptor gene BsmI and TaqI polymorphisms and fracture risk: a meta-analysis. Bone. 2006;39:938-945.
32. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266-281.
33. Gomez Alonso C, Naves Díaz ML, Díaz-Corte C, Fernández Martín JL, Cannata Andía JB. Vitamin D receptor gene (VDR) polymorphisms: effect on bone mass, bone loss and parathyroid hormone regulation. Nephrol Dial Transplant. 1998;13(Suppl 3):73-77.
34. Liu YZ, Liu YJ, Recker RR, Deng HW. Molecular studies of identification of genes for osteoporosis: the 2002 update. J Endocrinol. 2003;177:147-196.
35. Uitterlinden AG, Ralston SH, Brandi ML, et al. The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann Intern Med. 2006;145:255-264.
36. Howard G, Nguyen T, Morrison N, et al. Genetic influences on bone density: physiological correlates of vitamin D receptor gene alleles in premenopausal women. Notification of genotype corrections [letter]. J Clin Endocrinol Metab. 1998;83:1043.
37. Howard G, Nguyen T, Morrison N, et al. Genetic influences on bone density: physiological correlates of vitamin D receptor gene alleles in premenopausal women. J Clin Endocrinol Metab. 1995;80:2800-2805.
38. Kroger H, Mahonen A, Ryhanen S, Turunen AM, Alhava E, Maenpaa P. Vitamin D receptor genotypes and bone mineral density [letter]. Lancet. 1995;345:1238. [author reply 1995;345:1239].
39. McClure L, Eccleshall TR, Gross C, et al. Vitamin D receptor polymorphisms, bone mineral density, and bone metabolism in postmenopausal Mexican-American women. J Bone Miner Res. 1997;12:234-240.
40. Morrison NA, Yeoman R, Kelly PJ, Eisman JA. Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci U S A. 1992;89:6665-6669.
41. Ferrari S, Manen D, Bonjour JP, Slosman D, Rizzoli R. Bone mineral mass and calcium and phosphate metabolism in young men: relationships with vitamin D receptor allelic polymorphisms. J Clin Endocrinol Metab. 1999;84:2043-2048.
42. Fleet JC, Harris SS, Wood RJ, Dawson-Hughes B. The BsmI vitamin D receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopausal black and white women. J Bone Miner Res. 1995;10:985-990.
43. Graafmans WC, Lips P, Ooms ME, van Leeuwen JP, Pols HA, Uitterlinden AG. The effect of vitamin D supplementation on the bone mineral density of the femoral neck is associated with vitamin D receptor genotype. J Bone Miner Res. 1997;12:1241-1245.
44. Hansen TS, Abrahamsen B, Henriksen FL, et al. Vitamin D receptor alleles do not predict bone mineral density or bone loss in Danish perimenopausal women. Bone. 1998;22:571-575.
45. Ohtera K, Ishii S, Matsuyama T. Influence of the vitamin D receptor alleles on human osteoblast-like cells. J Bone Joint Surg Br. 2001;83:134-138.
46. Fernandez E, Fibla J, Betriu A, Piulats JM, Almirall J, Montoliu J. Association between vitamin D receptor gene polymorphism and relative hypoparathyroidism in patients with chronic renal failure. J Am Soc Nephrol. 1997;8:1546-1552.
47. Llach F, Velasquez Forero F. Secondary hyperparathyroidism in chronic renal failure: pathogenic and clinical aspects. Am J Kidney Dis. 2001;38:S20-S33.
48. Carling T, Rastad J, Szabo E, Westin G, Akerstrom G. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism. J Clin Endocrinol Metab. 2000;85:2000-2003.
49. Dusso AS, Thadhani R, Slatopolsky E. Vitamin D receptor and analogs. Semin Nephrol. 2004;24:10-16.
50. Carling T, Kindmark A, Hellman P, et al. Vitamin D receptor genotypes in primary hyperparathyroidism. Nat Med. 1995;1:1309-1311.
51. Carling T, Kindmark A, Hellman P, Holmberg L, Akerstrom G, Rastad J. Vitamin D receptor alleles b, a, and T: risk factors for sporadic primary hyperparathyroidism (HPT) but not HPT of uremia or MEN 1. Biochem Biophys Res Commun. 1997;231:329-332.
52. Carling T, Ridefelt P, Hellman P, Rastad J, Akerstrom G. Vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism. J Clin Endocrinol Metab. 1997;82:1772-1775.
53. Menarguez J, Goicoechea M, Crist bal E, et al. Lack of relationship between BsmI vitamin D receptor polymorphism and primary hyperparathyroidism in a Spanish female population. Calcif Tissue Int. 1999;65:214-216.
54. Nagasaka S, Ishikawa S, Matoba H, Kubota K, Murakami T, Saito T. Vitamin D receptors and hyperparathyroidism. Nat Med. 1996;2:834.
55. Lorentzon M, Lorentzon R, Nordstrom P. Vitamin D receptor gene polymorphism is related to bone density, circulating osteocalcin, and parathyroid hormone in healthy adolescent girls. J Bone Miner Metab. 2001;19:302-307.
56. Zofkova I, Zajickova K, Hill M. Serum parathyroid hormone levels are associated with FokI polymorphism of the vitamin D receptor gene in untreated postmenopausal women. Eur J Intern Med. 2003;14:232-236.
57. Nagaba Y, Heishi M, Tazawa H, Tsukamoto Y, Kobayashi Y. Vitamin D receptor gene polymorphisms affect secondary hyperparathyroidism in hemodialyzed patients. Am J Kidney Dis. 1998;32:464-469.
58. Giannini S, D'Angelo A, Nobile M, et al. The effects of vitamin D receptor polymorphism on secondary hyperparathyroidism and bone density after renal transplantation. J Bone Miner Res. 2002;17:1768-1773.
59. Vigo Gago E, Cadarso-Suarez C, Perez-Fernandez R, Romero Burgos R, Devesa Mugica J, Segura Iglesias C. Association between vitamin D receptor FokI polymorphism and serum parathyroid hormone level in patients with chronic renal failure. J Endocrinol Invest. 2005;28:117-121.
60. Alvarez-Hernandez D, Gonzalez-Suarez I, Carrillo-Lopez N, Naves-Diaz M, Anguita-Velasco J, Cannata-Andia JB. Viability and functionality of fresh and cryopreserved human hyperplastic parathyroid tissue tested in vitro. Am J Nephrol. 2008;28:76-82.
61. Alvarez-Hernandez D, Gonzalez-Suarez I, Naves M, et al. Long-term response of cultured rat parathyroid glands to calcium and calcitriol: the effect of cryopreservation. J Nephrol. 2005;18:141-147.
62. McCarey D, Spooner R, Jagger C, McLellan AR, Jardine AG. The BSM-1 vitamin D receptor polymorphism and secondary hyperparathyroidism. Nephrol Dial Transplant. 1998;13:811-812.
63. Marco MP, Martinez I, Betriu A, Craver L, Fibla MJ, Fernandez E. Influence of Bsml vitamin D receptor gene polymorphism on the response to a single bolus of calcitriol in hemodialysis patients. Clin Nephrol. 2001;56:111-116.
64. Torres A, Salido E. Vitamin D receptor genotype: its role in bone mass and turnover in non-renal and renal patients. Nephrol Dial Transplant. 1997;12:1811-1812.